Toshihiro Miyamoto - Concepedia

Author

Toshihiro Miyamoto

Also Known As

For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jun Taguchi, Ken Takase, Koichi Akashi, Koji Nagafuji, Naokuni Uike, T Miyamoto, T. MIYAMOTO, T. Miyamoto, T., Miyamoto

542

Publications

19K

Citations

H-Index

151

Concepts

All Affiliations

Kyushu University Kyushu University Hospital Hamanomachi Hospital Harasanshin Hospital Nagoya University

About

Toshihiro Miyamoto is an author at Kyushu University specializing in medicine, immunology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	93	8.6K
2	Health Sciences	19	28	4.8K
3	Public Health	4	4	154
4	Engineering	1	1	10
5	Biochemistry	1	1	41

Toshihiro Miyamoto

191

Publications

17.7K

Citations

H-Index

Page 1

	Year	Citations
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages Koichi Akashi, David Traver, Toshihiro Miyamoto, Nature Hematological MalignancyDevelopmental BiologyCytogeneticsMedicineGenetics	2000	2.5K
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region Fumihiko Ishikawa, Shuro Yoshida, Yoriko Saito, Nature Biotechnology Regenerative MedicineCell TherapyMedicineStem Cell TransplantationBone-marrow Endosteal Region	2007	966
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice Fumihiko Ishikawa, Masaki Yasukawa, Bonnie Lyons, Blood	2005	915
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study Takashi Ishida, Tatsuro Joh, Naokuni Uike, Journal of Clinical Oncology	2012	639
Prospective isolation of human clonogenic common myeloid progenitors Markus G. Manz, Toshihiro Miyamoto, Koichi Akashi, Proceedings of the National Academy of Sciences	2002	513
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells Yoshikane Kikushige, Takahiro Shima, Shin‐ichiro Takayanagi, Cell stem cell Hematological MalignancyCell TherapyMedicineMalignant Blood DisorderImmunology	2010	475
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation Toshihiro Miyamoto, Irving L. Weissman, Koichi Akashi Proceedings of the National Academy of Sciences	2000	459
AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations Youzhong Yuan, Liming Zhou, Toshihiro Miyamoto, Proceedings of the National Academy of Sciences	2001	430
Myeloid or Lymphoid Promiscuity as a Critical Step in Hematopoietic Lineage Commitment Toshihiro Miyamoto, Hiromi Iwasaki, Boris Reizis, Developmental Cell Hematological MalignancyCritical StepHematopoietic Lineage CommitmentLymphoid PromiscuityGenetics	2002	413
Dendritic cell potentials of early lymphoid and myeloid progenitors Markus G. Manz, David Traver, Toshihiro Miyamoto, Blood	2001	390

Page 1